CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 15 enrolled
Drug / intervention
Refresh Tears Lubricant Eye Drops (Allergan)drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01682460
NCT01682460Phase 4Completed
CompareCT.gov

Pilot Study on the Use of Artificial Tears to Treat Dry Eye in Glaucoma Patients

University of Waterloo·interventional·Posted Sep 11, 2012·Updated Jun 5, 2017

In Brief

A Phase 4 clinical trial evaluating Refresh Tears Lubricant Eye Drops (Allergan) for Glaucoma and Dry Eyes. Completed, enrolled 15 participants across 1 site.

Detailed Summary

Research indicates that many people who are being treated for glaucoma have dry eyes. The purpose of this study is to test the use of artificial tears to alleviate dryness signs and symptoms in people who are using medication to treat glaucoma. The study hypothesis is that the use of artificial tears will result in an improvement in clinical signs and symptoms associated with dry eyes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma, Dry Eyes
CountriesCanada
CollaboratorsAllergan

Timeline

Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedSep 11, 2012
Enrollment StartAug 1, 2012
Primary CompletionApr 1, 2013
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 13.8 years ago

Interventions

Refresh Tears Lubricant Eye Drops (Allergan)drug

Eye drops QID for 1 month